ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
0,5158
-0,0755
(-12,77%)
Geschlossen 06 Juni 10:00PM
0,5002
-0,0156
(-3,02%)
Nach Börsenschluss: 1:55AM

AIM ImmunoTech Inc (AIM) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,5002
( -15,41% )
Gebot
-
Fragen
-
Volumen
7.691.512
0,471101 Tagesbereich 0,588
0,0949 52-Wochen-Bereich 20,35
Marktkapitalisierung
Handelsende
0,5913
Handelsbeginn
0,5479
Letzte Trade
39015
@
0.5158
Letzter Handelszeitpunkt
Finanzvolumen
US$ 4.034.562
VWAP
0,524547
Durchschnittliches Volumen (3 Mio.)
US$ 3.558.175
Ausgegebene Aktien
8.147.782
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0,04
Gewinn pro Aktie (EPS)
-6,69
Erlöse (LTM)
94k
Nettogewinn (LTM)
-13,28M

Über AIM ImmunoTech Inc

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company’s flagship products are Ampligen (rintatolimod), a drug of large macromolecular... AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company’s flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Ocala, United States
Gegründet
1966
AIM ImmunoTech Inc is listed in the Healthcare sector of the Amerikanische Börse with ticker AIM. The last closing price for AIM ImmunoTech was US$0,59. Over the last year, AIM ImmunoTech shares have traded in a share price range of US$ 0,0949 to US$ 20,35.

AIM ImmunoTech currently has 8.147.782 shares in issue. The market capitalisation of AIM ImmunoTech is US$4,08 million. AIM ImmunoTech has a price to earnings ratio (PE ratio) of -0.04.

AIM Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.09523.44521224090.40521.250.3804899134700.84754973CS
40.140238.94444444440.361.250.21816296680.53117127CS
12-0.1998-28.54285714290.71.620.21303705850.58465375CS
26-0.9898-66.42953020131.491.87990.21148959270.61343561CS
520.4053427.081138040.094920.350.094974538480.64327376CS
1560.068915.9749594250.431320.350.063326944290.6152011CS
260-1.6098-76.29383886262.1120.350.063317267640.65629435CS

AIM - Frequently Asked Questions (FAQ)

What is the current AIM ImmunoTech Inc share price?
The current share price of AIM ImmunoTech Inc is US$ 0,5002
How many AIM ImmunoTech Inc shares are in issue?
AIM ImmunoTech Inc has 8.147.782 shares in issue
What is the market cap of AIM ImmunoTech Inc?
The market capitalisation of AIM ImmunoTech Inc is USD 4,08M
What is the 1 year trading range for AIM ImmunoTech Inc share price?
AIM ImmunoTech Inc has traded in the range of US$ 0,0949 to US$ 20,35 during the past year
What is the PE ratio of AIM ImmunoTech Inc?
The price to earnings ratio of AIM ImmunoTech Inc is -0,04
What is the cash to sales ratio of AIM ImmunoTech Inc?
The cash to sales ratio of AIM ImmunoTech Inc is 21,93
What is the registered address of AIM ImmunoTech Inc?
The registered address for AIM ImmunoTech Inc is 2117 SW Highway 484, Ocala, Florida, 34473
What is the AIM ImmunoTech Inc website address?
The website address for AIM ImmunoTech Inc is aimimmuno.com
Which industry sector does AIM ImmunoTech Inc operate in?
AIM ImmunoTech Inc operates in the Biotechnology & Life Sciences sector

AIM Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen